tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TAK Stock Latest News

Takeda Pharmaceutical: Resilient Growth and Strong Sales Ambition Justify Buy Rating
RatingsTakeda Pharmaceutical: Resilient Growth and Strong Sales Ambition Justify Buy Rating
8h ago
TAK
Veeva has ‘meaningful’ Life Science head start over Salesforce, says Oppenheimer
PremiumThe Fly
Veeva has ‘meaningful’ Life Science head start over Salesforce, says Oppenheimer
2d ago
CRM
TAK
Takeda publishes oveporexton data in New England Journal of Medicine
PremiumThe Fly
Takeda publishes oveporexton data in New England Journal of Medicine
7d ago
TAK
Takeda Pharmaceutical Reports April 2025 Share Repurchase Progress
PremiumCompany Announcements
Takeda Pharmaceutical Reports April 2025 Share Repurchase Progress
7d ago
6K
TAK
Takeda’s Earnings Call Highlights Growth Amid Challenges
PremiumCompany Announcements
Takeda’s Earnings Call Highlights Growth Amid Challenges
11d ago
TAK
Takeda Pharmaceutical Reports Strong Growth Amid Challenges
PremiumCompany AnnouncementsTakeda Pharmaceutical Reports Strong Growth Amid Challenges
12d ago
TAK
Novavax announces improved terms for nuvaxovid agreement with Takeda in Japan
Premium
The Fly
Novavax announces improved terms for nuvaxovid agreement with Takeda in Japan
16d ago
TAK
NVAX
CHMP gives positive opinion on variation to marketing authorization for Adcetris
Premium
The Fly
CHMP gives positive opinion on variation to marketing authorization for Adcetris
26d ago
TAK
Takeda Completes Significant Share Repurchase in March 2025
PremiumCompany Announcements
Takeda Completes Significant Share Repurchase in March 2025
1M ago
6K
TAK
Takeda upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Takeda upgraded to Overweight from Equal Weight at Morgan Stanley
2M ago
TAK
Takeda Canada says Health Canada expands marketing authorization for HyQvia
PremiumThe Fly
Takeda Canada says Health Canada expands marketing authorization for HyQvia
2M ago
TAK
Mirum Pharmaceuticals partner Takeda receives approval for Livmarli in Japan
PremiumThe Fly
Mirum Pharmaceuticals partner Takeda receives approval for Livmarli in Japan
2M ago
TAK
MIRM
Harmony Biosciences CCO Jeffrey Dierks steps down, Adam Zaeske succeedsTakeda
PremiumThe FlyHarmony Biosciences CCO Jeffrey Dierks steps down, Adam Zaeske succeedsTakeda
2M ago
TAK
HRMY
Takeda Announces Share Repurchase Program for February 2025
Premium
Company Announcements
Takeda Announces Share Repurchase Program for February 2025
2M ago
6K
TAK
Takeda announces EMA approval for Takhzyro two mL pre-filled pen option
Premium
The Fly
Takeda announces EMA approval for Takhzyro two mL pre-filled pen option
3M ago
TAK
Takeda Announces Share Repurchase Plan for 2025
PremiumCompany Announcements
Takeda Announces Share Repurchase Plan for 2025
3M ago
6K
TAK
Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed
PremiumThe Fly
Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed
4M ago
TAK
Takeda’s Earnings Call Reveals Mixed Performance, Optimistic Outlook
PremiumCompany Announcements
Takeda’s Earnings Call Reveals Mixed Performance, Optimistic Outlook
4M ago
TAK
Vivek Ramaswamy’s Net Worth – The Youngest Billionaire Republican Presidential Candidate
PremiumMarket News
Vivek Ramaswamy’s Net Worth – The Youngest Billionaire Republican Presidential Candidate
4M ago
RUM
TAK
TAK Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsTAK Upcoming Earnings Report: What to Expect?
4M ago
TAK
Neurocrine announces amendment to collaboration with Takeda
Premium
The Fly
Neurocrine announces amendment to collaboration with Takeda
4M ago
TAK
NBIX
Avadel names Sev Melkonian as VP, patient services, distribution, reimbursement
Premium
The Fly
Avadel names Sev Melkonian as VP, patient services, distribution, reimbursement
4M ago
TAK
AVDL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >